Knight Therapeutics Investor Relations Material
Latest events
M&A Announcement
Knight Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Knight Therapeutics Inc
Access all reports
Knight Therapeutics Inc is a Canadian specialty pharmaceutical company that acquires, licenses, and commercializes prescription medicines for the Canadian and Latin American markets. The company focuses on late-stage or commercial products across therapeutic areas such as oncology, infectious diseases, and ophthalmology. Knight Therapeutics Inc is headquartered in Montreal, Canada, and its shares are listed on the TSX.
Latest articles
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
)
D. E. Shaw & Co: Inside the Quiet Giant of Quant Finance
A deep dive into D. E. Shaw's evolution from a $28M quant startup to a $65B hedge fund giant, built on research, computing, and quiet consistency.
2 Jul 2025
)
Pershing Square Capital Management: Conviction, Reinvention, and Contrarian Investing
Pershing Square Capital Management has grown into a top-tier hedge fund through reinvention, conviction, and focus on long-term value creation.
2 Jul 2025
Ticker symbol
GUD
Country
🇨🇦 Canada